GLP-1
Importantly, GLP-1 receptor agonists are not recommended during pregnancy or breastfeeding
This iron regulation proves important for preventing brain damage and neuron death
The appetite suppression effects can be additive, which is usually clinically fine but worth noting
has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
doi: 10.1016/j.freeradbiomed.2020.07.026 16 KremerDMNelsonBSLinLYaroszELHalbrookCJKerkSAet al